RR

Rama Raju Devaraju

Director DIN 08353744
DIN 08353744 First appointment Feb 2019
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Rama Raju Devaraju

Data last updated:

Rama Raju Devaraju was a Director at Advasol Biocare Private Limited (from 2019) and Managing Director at Ramah Bio Solutions Private Limited (from 2020).

DIN 08353744
First Appointment 06 Feb 2019
Oldest Company Age 7 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Advasol Biocare Private Limited U85300TG2019PTC130331
Director06 Feb 20192019Strike Off
Ramah Bio Solutions Private Limited U51397TG2020PTC139229
Managing Director14 Feb 20202020Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Advasol Biocare Private Limited
Ramah Bio Solutions Private Limited
Premium access

Shareholding and investment profile for Rama Raju Devaraju

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rama Raju Devaraju

Rama Raju Devaraju was first appointed on 06 Feb 2019 as Director at Advasol Biocare Private Limited. The most recent appointment on record is 14 Feb 2020 at Ramah Bio Solutions Private Limited.

Rama Raju Devaraju held 2 earlier board appointments: Advasol Biocare Private Limited (Director, from 06 Feb 2019); Ramah Bio Solutions Private Limited (Managing Director, from 14 Feb 2020).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available